These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25344917)

  • 1. TM4SF4 overexpression in radiation-resistant lung carcinoma cells activates IGF1R via elevation of IGF1.
    Choi SI; Kim SY; Lee J; Cho EW; Kim IG
    Oncotarget; 2014 Oct; 5(20):9823-37. PubMed ID: 25344917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bidirectional signaling between TM4SF5 and IGF1R promotes resistance to EGFR kinase inhibitors.
    Choi J; Kang M; Nam SH; Lee GH; Kim HJ; Ryu J; Cheong JG; Jung JW; Kim TY; Lee HY; Lee JW
    Lung Cancer; 2015 Oct; 90(1):22-31. PubMed ID: 26190015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGF1/IGF1R/STAT3 signaling-inducible IFITM2 promotes gastric cancer growth and metastasis.
    Xu L; Zhou R; Yuan L; Wang S; Li X; Ma H; Zhou M; Pan C; Zhang J; Huang N; Shi M; Bin J; Liao Y; Liao W
    Cancer Lett; 2017 May; 393():76-85. PubMed ID: 28223169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibulin-3-mediated inhibition of epithelial-to-mesenchymal transition and self-renewal of ALDH+ lung cancer stem cells through IGF1R signaling.
    Kim IG; Kim SY; Choi SI; Lee JH; Kim KC; Cho EW
    Oncogene; 2014 Jul; 33(30):3908-17. PubMed ID: 24013232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAK1 Is a Novel Therapeutic Target in Tyrosine Kinase Inhibitor-Resistant Lung Adenocarcinoma Activated by the PI3K/AKT Signaling Regardless of EGFR Mutation.
    Wu DW; Wu TC; Chen CY; Lee H
    Clin Cancer Res; 2016 Nov; 22(21):5370-5382. PubMed ID: 27178741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the IGF1R pathway potentially mediates acquired resistance to mutant-selective 3rd-generation EGF receptor tyrosine kinase inhibitors in advanced non-small cell lung cancer.
    Park JH; Choi YJ; Kim SY; Lee JE; Sung KJ; Park S; Kim WS; Song JS; Choi CM; Sung YH; Rho JK; Lee JC
    Oncotarget; 2016 Apr; 7(16):22005-15. PubMed ID: 26980747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET.
    Chen QY; Jiao DM; Wang J; Hu H; Tang X; Chen J; Mou H; Lu W
    Oncotarget; 2016 Apr; 7(17):24510-26. PubMed ID: 27014910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implication of epithelial-mesenchymal transition in IGF1R-induced resistance to EGFR-TKIs in advanced non-small cell lung cancer.
    Zhou J; Wang J; Zeng Y; Zhang X; Hu Q; Zheng J; Chen B; Xie B; Zhang WM
    Oncotarget; 2015 Dec; 6(42):44332-45. PubMed ID: 26554308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of VBMDMP on the reversal of cisplatin resistance in human lung cancer A549/DDP cells.
    Wang CK; Zhang Y; Zhang ZJ; Qiu QW; Cao JG; He ZM
    Oncol Rep; 2015 Jan; 33(1):372-82. PubMed ID: 25394854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of TBC1 Domain Family Member 24 (BC1D24) Inhibits Breast Carcinoma Growth via IGF1R/PI3K/AKT Pathway.
    Qu X; Zhao B; Hu M; Ji Z; Xu J; Xia W; Qu Y
    Med Sci Monit; 2018 Jun; 24():3987-3996. PubMed ID: 29893377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteopontin production by TM4SF4 signaling drives a positive feedback autocrine loop with the STAT3 pathway to maintain cancer stem cell-like properties in lung cancer cells.
    Choi SI; Kim SY; Lee JH; Kim JY; Cho EW; Kim IG
    Oncotarget; 2017 Nov; 8(60):101284-101297. PubMed ID: 29254164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy-Activated Cancer-Associated Fibroblasts Promote Tumor Progression through Paracrine IGF1R Activation.
    Tommelein J; De Vlieghere E; Verset L; Melsens E; Leenders J; Descamps B; Debucquoy A; Vanhove C; Pauwels P; Gespach CP; Vral A; De Boeck A; Haustermans K; de Tullio P; Ceelen W; Demetter P; Boterberg T; Bracke M; De Wever O
    Cancer Res; 2018 Feb; 78(3):659-670. PubMed ID: 29217764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct Afatinib Resistance Mechanisms Identified in Lung Adenocarcinoma Harboring an EGFR Mutation.
    Yamaoka T; Ohmori T; Ohba M; Arata S; Murata Y; Kusumoto S; Ando K; Ishida H; Ohnishi T; Sasaki Y
    Mol Cancer Res; 2017 Jul; 15(7):915-928. PubMed ID: 28289161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation resistance of the lung adenocarcinoma is related to the AKT-Onzin-POU5F1 axis.
    Jin Z; Guan L; Xiang GM; Gao BA
    Biochem Biophys Res Commun; 2018 May; 499(3):538-543. PubMed ID: 29596836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CNTN-1 Enhances Chemoresistance in Human Lung Adenocarcinoma Through Induction of Epithelial-Mesenchymal Transition by Targeting the PI3K/Akt Pathway.
    Zhang R; Sun S; Ji F; Liu C; Lin H; Xie L; Yang H; Tang W; Zhou Y; Xu J; Li P
    Cell Physiol Biochem; 2017; 43(2):465-480. PubMed ID: 28934754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression.
    Dong S; Qu X; Li W; Zhong X; Li P; Yang S; Chen X; Shao M; Zhang L
    J Hematol Oncol; 2015 Apr; 8():43. PubMed ID: 25925741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncostatin m modulates the mesenchymal-epithelial transition of lung adenocarcinoma cells by a mesenchymal stem cell-mediated paracrine effect.
    Wang ML; Pan CM; Chiou SH; Chen WH; Chang HY; Lee OK; Hsu HS; Wu CW
    Cancer Res; 2012 Nov; 72(22):6051-64. PubMed ID: 23139208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anthricin‑induced caspase‑dependent apoptosis through IGF1R/PI3K/AKT pathway inhibition in A549 human non‑small lung cancer cells.
    Park BR; Lee SA; Moon SM; Kim CS
    Oncol Rep; 2018 Jun; 39(6):2769-2776. PubMed ID: 29620219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the IGF signaling pathway reverses cisplatin resistance in ovarian cancer cells.
    Du J; Shi HR; Ren F; Wang JL; Wu QH; Li X; Zhang RT
    BMC Cancer; 2017 Dec; 17(1):851. PubMed ID: 29241458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways.
    Meng J; Zhang XT; Liu XL; Fan L; Li C; Sun Y; Liang XH; Wang JB; Mei QB; Zhang F; Zhang T
    Cell Signal; 2016 Nov; 28(11):1673-82. PubMed ID: 27449264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.